1-7 of 7
Keywords: Thiopurines
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Gastroenterology
Dig Dis (2024) 42 (3): 257–264.
Published Online: 08 March 2024
... Roig-Ramos; María Isabel Vera; Ángel Carracedo; Eugeni Domènech; Javier P. Gisbert; ENEIDA Project of GETECCU Introduction: Risk factors for developing pancreatitis due to thiopurines in patients with inflammatory bowel disease (IBD) are not clearly identified. Our aim was to evaluate the predictive...
Journal Articles
Subject Area:
Gastroenterology
Dig Dis (2016) 34 (Suppl. 1): 56–60.
Published Online: 22 August 2016
... that thiopurines are not effective for induction of remission; thus our focus will be on the role in maintenance of remission and steroid sparing [ 5, 6 ]. Crohn’s disease Thiopurines Maintenance of remission Historically, in the 1950s, the introduction of simple, old-fashioned...
Journal Articles
Dig Dis (2016) 34 (1-2): 125–131.
Published Online: 16 March 2016
...Ala I. Sharara Background: Immunomodulators (IMMs), including thiopurines (TPs) and methotrexate (MTX), are commonly used in the treatment of inflammatory bowel disease (IBD). Key Messages: In ulcerative colitis (UC), TPs have modest steroid-sparing effects and established efficacy in maintenance...
Journal Articles
Subject Area:
Gastroenterology
Dig Dis (2014) 32 (Suppl. 1): 122–127.
Published Online: 17 December 2014
... thiopurines, methotrexate and anti-TNFα biologics. The procarcinogenic effect of IMS depends on the type of drug and length of exposure. Thiopurines increase the rates of nonmelanoma skin cancer and lymphomas. Methotrexate is less harmful, but data are scarce. Evidence favoring the ‘safety' of anti-TNF...
Journal Articles
Subject Area:
Gastroenterology
Dig Dis (2014) 32 (4): 399–402.
Published Online: 23 June 2014
... to preventing relapse, hospital admission and surgery, and improving disease natural history. Options for remission maintenance include smoking cessation, thiopurines, methotrexate, anti-TNF-α drugs and surgery. Evidence suggests that in some places now, and in most places in the past, too few patients are/were...
Journal Articles
Subject Area:
Gastroenterology
Dig Dis (2014) 32 (4): 345–350.
Published Online: 23 June 2014
... decades have seen a dramatic shift in therapeutic approach with the increasingly common use of early thiopurine immunomodulation. These maintenance medications were initially introduced primarily as corticosteroid-sparing agents capable of minimizing recurrent flares of inflammatory disease and have...
Journal Articles
Subject Area:
Gastroenterology
Dig Dis (2014) 32 (4): 410–418.
Published Online: 23 June 2014
...Peter M. Irving The use of biologics and thiopurines in patients with inflammatory bowel disease has increased rapidly over the last 2 decades with both classes of drugs being used more frequently and earlier in the disease course. This vogue has come about through a realisation that for some...